Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase pigmentation in young hamsters, but estrogens can reverse this effect.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Balding men had lower bone density, while balding women had higher hip bone density.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Estrogen formation in hair roots affects hair growth and varies by site, gender, and age.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Gynecomastia and premature thelarche often resolve naturally but need evaluation to rule out serious issues.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Dihydrotestosterone might cause migraines, and finasteride could help reduce them.

Sex hormones influence immune responses and may help treat diseases.

Low estrogen compared to androgen may cause female hair loss.